©2024 Stanford Medicine
Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
Not Recruiting
Trial ID: NCT00610415
Purpose
To see if a limited sampling of tumor tissue from human subjects is a feasible way to gather
adequate tissue for cancer stem cell quantification.
Official Title
Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
Stanford Investigator(s)
A. Dimitrios Colevas, MD
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
Quynh-Thu Le, MD
Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)
Maximilian Diehn, MD, PhD
Jack, Lulu, and Sam Willson Professor and Professor of Radiation Oncology (Radiation Therapy)
Harlan Pinto
Associate Professor of Medicine (Oncology) and of Otolaryngology - Head & Neck Surgery
Eligibility
Inclusion Criteria:1. Patients with malignant tumors seen at the Stanford University Cancer
Center. Eligible patients will have a diagnosis of squamous cell carcinoma (HNSCC) and will
have been seen in the Stanford Head and Neck Oncology Program. A decision to undergo
surgery at Stanford will have been made, prior to recruiting patients for the study, and
prior to obtaining the samples during surgery. (Histological confirmation of the diagnosis
need not be made prior to obtaining consent.) 2. A definitive resection of a malignant
tumor is planned. 3. Surgeon judgment that the definitive procedure will not be compromised
by including
- FNA
- Core needle biopsy
- Cup forceps or punch biopsy of<4mm. 4. Informed consent documented prior to procedure
Intervention(s):
procedure: tumor biopsy
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
ccto-office@stanford.edu
650-498-7061